Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet function testing after heart transplantation on aspirin therapy
2025-521699-71-01Phase 4Authorised
- Sponsor
- Medical University of Vienna
- Start
- May 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aspirin in heart transplantation and cardiac morbidity, sponsored by Medical University of Vienna. Primary endpoint: Presence of aspirin resistance. Planned start May 2026; status: authorised.
02
Drugs
aspirin
03
Conditions
heart transplantationcardiac morbidity
Beyond the preview
Go deeper on 2025-521699-71-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521699-71-01.